| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 989 | 966 | 371 |
| Full Text Views | 320 | 4 | 2 |
| PDF Downloads | 82 | 5 | 3 |
Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in Southern Mauritania.
T Jelinek
T Jelinek
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by T Jelinek in
Current site
Google Scholar
PubMed
Search for other papers by T Jelinek in
Current site
Google Scholar
PubMed
A O Aida
A O Aida
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by A O Aida in
Current site
Google Scholar
PubMed
Search for other papers by A O Aida in
Current site
Google Scholar
PubMed
G Peyerl-Hoffmann
G Peyerl-Hoffmann
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by G Peyerl-Hoffmann in
Current site
Google Scholar
PubMed
Search for other papers by G Peyerl-Hoffmann in
Current site
Google Scholar
PubMed
S Jordan
S Jordan
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by S Jordan in
Current site
Google Scholar
PubMed
Search for other papers by S Jordan in
Current site
Google Scholar
PubMed
A Mayor
A Mayor
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by A Mayor in
Current site
Google Scholar
PubMed
Search for other papers by A Mayor in
Current site
Google Scholar
PubMed
C Heuschkel
C Heuschkel
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by C Heuschkel in
Current site
Google Scholar
PubMed
Search for other papers by C Heuschkel in
Current site
Google Scholar
PubMed
A O el Valy
A O el Valy
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by A O el Valy in
Current site
Google Scholar
PubMed
Search for other papers by A O el Valy in
Current site
Google Scholar
PubMed
F von Sonnenburg
F von Sonnenburg
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by F von Sonnenburg in
Current site
Google Scholar
PubMed
Search for other papers by F von Sonnenburg in
Current site
Google Scholar
PubMed
E M Christophel
E M Christophel
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany. jelinek@lrz.uni-muenchen.de
Search for other papers by E M Christophel in
Current site
Google Scholar
PubMed
Search for other papers by E M Christophel in
Current site
Google Scholar
PubMed
Despite its diminishing efficacy because of increased resistance, chloroquine remains the primary antimalarial agent in many endemic areas. Evidence is mounting that point mutations on the Pfcrt and possibly the Pfmdr1 genes are conferring plasmodial resistance to chloroquine. In 1998, atypically strong rainfalls led to an increased activity of falciparum malaria in Mauritania that affected non-endemic regions bordering the Saharan desert. An in vivo study on chloroqine resistance was combined with studies for molecular markers of drug resistance. Detection of Pfmdr1-76-tyrosine showed an increased odds ratio (2.91) for resistance (P = 0.0195). However, by use of this codon alone, sensitivity for detection of resistance was 60.6%, and specificity was 65.3%. In comparison, detection of the K76T mutation at Pfcrt showed a very high sensitivity (100%) while specificity remained relatively low (65.4%). For the combination of mutations on both genes, the odds ratio for detection of resistance increased to 5.31 (P = 0.0005). Here, sensitivity was again decreased to 60.6% while specificity increased to 76.9%. The results of this study suggest that detection of Pfcrt T76 can be applied for predicting chloroquine resistance in epidemiologic settings with sufficiently high sensitivity to make it an attractive alternative to time- and labor-consuming in vivo trials. Additional testing for Pfmdr Y76 provides increased specificity to this approach.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 989 | 966 | 371 |
| Full Text Views | 320 | 4 | 2 |
| PDF Downloads | 82 | 5 | 3 |